Patents Assigned to Theracell Laboratories
  • Publication number: 20260256987
    Abstract: Disclosed herein is an autologous composition comprising mesenchymal stem stromal cells, wherein the mesenchymal stem stromal cells are derived from adipose tissue collected by punch biopsy from a subject, and the use for the treatment of a disease, including a disease with arthritic lesion progression.
    Type: Application
    Filed: May 17, 2023
    Publication date: September 3, 2026
    Applicants: Theracell Laboratories, Orgenesis Inc.
    Inventors: FOTIOS SAKELLARIDIS, POLYCHRONIS FATOUROS, MARIA KONTOU